Pharmacokinetics–pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients

RP Veiga, JA Paiva - Critical Care, 2018 - Springer
Antimicrobials are among the most important and commonly prescribed drugs in the
management of critically ill patients and beta-lactams are the most common antibiotic class …

Therapeutic drug monitoring of anti-infective agents in critically ill patients

NGL Jager, RM van Hest, J Lipman… - Expert review of …, 2016 - Taylor & Francis
Initial adequate anti-infective therapy is associated with significantly improved clinical
outcomes for patients with severe infections. However, in critically ill patients, several …

Optimizing antimicrobial drug dosing in critically ill patients

P Póvoa, P Moniz, JG Pereira, L Coelho - Microorganisms, 2021 - mdpi.com
A fundamental step in the successful management of sepsis and septic shock is early
empiric antimicrobial therapy. However, for this to be effective, several decisions must be …

Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients

F Barbier, S Hraiech, S Kernéis, N Veluppillai… - Annals of Intensive …, 2023 - Springer
Background Healthcare-associated infections involving Gram-negative bacteria (GNB) with
difficult-to-treat resistance (DTR) phenotype are associated with impaired patient-centered …

Pharmacokinetic/pharmacodynamic considerations for the optimization of antimicrobial delivery in the critically ill

D Tsai, J Lipman, JA Roberts - Current opinion in critical care, 2015 - journals.lww.com
Optimization of antimicrobial dosing in accordance with pharmacokinetics/
pharmacodynamics targets can improve survival and clinical cure. Dosing regimens for …

The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study

K Shekar, JF Fraser, FS Taccone, S Welch, SC Wallis… - Critical Care, 2014 - Springer
Introduction The scope of extracorporeal membrane oxygenation (ECMO) is expanding;
however, optimal drug prescription during ECMO remains a developing science. Currently …

Population pharmacokinetics and Monte Carlo dosing simulations of meropenem during the early phase of severe sepsis and septic shock in critically ill patients in …

S Jaruratanasirikul, S Thengyai… - Antimicrobial agents …, 2015 - Am Soc Microbiol
Pathophysiological changes during the early phase of severe sepsis and septic shock in
critically ill patients, resulting in altered pharmacokinetic (PK) patterns for antibiotics, are …

Development of a dosing nomogram for continuous-infusion meropenem in critically ill patients based on a validated population pharmacokinetic model

IK Minichmayr, JA Roberts, OR Frey… - Journal of …, 2018 - academic.oup.com
Background Optimal antibiotic exposure is a vital but challenging prerequisite for achieving
clinical success in ICU patients. Objectives To develop and externally validate a population …

Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study

L Ehmann, M Zoller, IK Minichmayr, C Scharf, B Maier… - Critical care, 2017 - Springer
Background Severe bacterial infections remain a major challenge in intensive care units
because of their high prevalence and mortality. Adequate antibiotic exposure has been …

Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients

F Mattioli, C Fucile, V Del Bono, V Marini… - European journal of …, 2016 - Springer
Purpose Patients admitted to intensive care unit (ICU) with Klebsiella pneumoniae infections
are characterized by high mortality. The aims of the present study were to investigate the …